The cellular peptidyl-prolyl cis/trans isomerase pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 547-558

  Guito, Jonathan ^a   Gavina, Aileen ^a   Palmeri, Diana ^a   Lukac, David M ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDYLPROLYL ISOMERASE PIN1; RTA PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; EMBRYO; ENZYME ACTIVITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSACTIVATION; VIRION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DNA REPLICATION; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDYLPROLYL ISOMERASE; PROMOTER REGIONS, GENETIC; SARCOMA, KAPOSI; SEQUENCE HOMOLOGY, AMINO ACID; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84890872996     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02877-13     Document Type: Article

References (69)

1. Gantt S, Casper C. 2011. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr. Opin. Infect. Dis. 24:295-301. http://dx.doi.org/10.1097/QCO.0b013e3283486d04.
2. Beral V, Peterman T, Berkelman R, Jaffe HW. 1990. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?. Lancet 335: 123-127. http://dx.doi.org/10.1016/0140-6736(90)90001-L.
3. Mosam A, Aboobaker J, Shaik F. 2010. Kaposi's sarcoma in sub-Saharan Africa: a current perspective. Curr. Opin. Infect. Dis. 23:119-123. http://dx.doi.org/10.1097/QCO.0b013e328335b01a.
4. Renne R, Lagunoff M, Zhong W, Ganem D. 1996. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70:8151-8154.
5. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U. S. A. 93:14862-14867. http://dx.doi.org/10.1073/pnas .93.25.14862.
6. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, Van Marck E, Salmon D, Gorin I, Escande J-P, Weiss RA, Alitalo K, Boshoff C. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. U. S. A. 96:4546-4551. http://dx.doi.org/10 .1073/pnas.96.8.4546.
7. Jenner R, Alba M, Boshoff C, Kellam P. 2001. Kaposi's sarcomaassociated herpesvirus latent and lytic gene expression as revealed byDNA arrays. J. Virol. 75:891-902. http://dx.doi.org/10.1128/JVI.75.2.891-902 .2001.
8. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346. http://dx.doi.org/10.1038/nm0396-342.
9. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719.
10. Sun R, Lin S-F, Staskus K, Gradoville L, Grogan E, Haase A, Miller G. 1999. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73:2232-2242.
11. Zhong W, Wang H, Herndier B, Ganem D. 1996. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. U. S. A. 93:6641-6646. http://dx .doi.org/10.1073/pnas.93.13.6641.
12. Lukac DM, Kirshner JR, Ganem D. 1999. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73:9348-9361.
13. Lukac DM, Renne R, Kirshner JR, Ganem D. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304-312. http://dx.doi.org/10.1006/viro.1998.9486.
14. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U. S. A. 95:10866-10871. http://dx.doi.org/10 .1073/pnas.95.18.10866.
15. Palmeri D, Spadavecchia S, Carroll K, Lukac DM. 2007. Promoter and cell-specific transcriptional activation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein. J. Virol. 81:13299-13314. http://dx.doi .org/10.1128/JVI.00732-07.
16. Han Z, Swaminathan S. 2006. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J. Virol. 80:5251-5260. http://dx.doi.org/10.1128/JVI.02570-05.
17. Kirshner JR, Lukac DM, Chang J, Ganem D. 2000. Kaposi's sarcomaassociated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J. Virol. 74:3586-3597. http://dx.doi.org/10.1128/JVI.74.8.3586-3597.2000.
18. Majerciak V, Pripuzova N, McCoy JP, Gao SJ, Zheng ZM. 2007. Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus. J. Virol. 81:1062-1071. http://dx.doi.org/10.1128/JVI.01558-06.
19. Carroll KD, Bu W, Palmeri D, Spadavecchia S, Lynch SJ, Marras SA, Tyagi S, Lukac DM. 2006. Kaposi's sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J. Virol. 80:9697-9709. http://dx.doi.org/10.1128/JVI .00746-06.
20. Liang Y, Chang J, Lynch S, Lukac DM, Ganem D. 2002. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jk, the target of the Notch signaling pathway. Genes Dev. 16:1977-1989. http://dx.doi.org/10.1101/gad.996502.
21. Liang Y, Ganem D. 2003. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 100:8490-8495. http://dx.doi.org/10.1073/pnas.1432843100.
22. Palmeri D, Carroll KD, Gonzalez-Lopez O, Lukac DM. 2011. Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL. J. Virol. 85:11901-11915. http://dx.doi.org/10.1128/JVI.05479 11.
23. Bu W, Carroll KD, Palmeri D, Lukac DM. 2007. The Kaposi's sarcomaassociated herpesvirus/human herpesvirus-8 ORF50/Rta lytic switch protein functions as a tetramer. J. Virol. 81:5788-5806. http://dx.doi.org/10 .1128/JVI.00140-07.
24. Lee TH, Pastorino L, Lu KP. 2011. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev. Mol. Med. 13: e21. http://dx.doi.org/10.1017/S1462399411001906.
25. Lu KP, Hanes SD, Hunter T. 1996. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380:544-547. http://dx.doi.org/10.1038/380544a0.
26. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang DG. 2004. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 164:1727-1737. http://dx.doi.org/10.1016/S0002-9440(10)63731-5.
27. Lu KP, Finn G, Lee TH, Nicholson LK. 2007. Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 3:619-629. http://dx.doi .org/10.1038/nchembio.2007.35.
28. Takahashi K, Uchida C, Shin RW, Shimazaki K, Uchida T. 2008. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. Cell. Mol. Life Sci. 65:359-375. http://dx.doi.org/10.1007/s00018-007-7270-0.
29. Atchison FW, Means AR. 2004. A role for Pin1 in mammalian germ cell development and spermatogenesis. Front. Biosci. 9:3248-3256. http://dx .doi.org/10.2741/1476.
30. Gallo G, Giordano A. 2005. Are RB proteins a potential substrate of Pin1 in the regulation of the cell cycle? J. Cell. Physiol. 205:176-181. http://dx .doi.org/10.1002/jcp.20451.
31. Ryo A, Liou YC, Wulf G, Nakamura M, Lee SW, Lu KP. 2002. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 22:5281-5295. http://dx.doi.org/10 .1128/MCB.22.15.5281-5295.2002.
32. Wulf G, Finn G, Suizu F, Lu KP. 2005. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 7:435-441. http://dx.doi.org/10.1038/ncb0505-435.
33. Wulf G, Ryo A, Liou YC, Lu KP. 2003. The prolyl isomerase Pin1 in breast development and cancer. Breast Cancer Res. 5:76-82. http://dx.doi .org/10.1186/bcr572.
34. Watashi K, Khan M, Yedavalli VR, Yeung ML, Strebel K, Jeang KT. 2008. Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. J. Virol. 82:9928-9936. http://dx.doi.org/10.1128/JVI.01017-08.
35. Peloponese JM, Jr, Yasunaga J, Kinjo T, Watashi K, Jeang KT. 2009. Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 Tax and modulates its activation of NF-kappaB. J. Virol. 83:3238-3248. http://dx.doi.org/10.1128/JVI.01824-08.
36. Saitoh T, Tun-Kyi A, Ryo A, Yamamoto M, Finn G, Fujita T, Akira S, Yamamoto N, Lu KP, Yamaoka S. 2006. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7:598-605. http://dx.doi.org/10.1038/ni1347.
37. Narita Y, Murata T, Ryo A, Kawashima D, Sugimoto A, Kanda T, Kimura H, Tsurumi T. 2013. Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication. J. Virol. 87:2120-2127. http://dx.doi.org/10.1128/JVI.02634-12.
38. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 77:4205-4220. http://dx.doi.org/10.1128/JVI.77.7.4205-4220.2003.
39. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J. Virol. 86:9708-9720. http://dx.doi.org/10.1128/JVI.01019-12.
40. Fujimori F, Takahashi K, Uchida C, Uchida T. 1999. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem. Biophys. Res. Commun. 265:658-663. http://dx.doi.org/10 .1006/bbrc.1999.1736.
41. Gantt S, Carlsson J, Ikoma M, Gachelet E, Gray M, Geballe AP, Corey L, Casper C, Lagunoff M, Vieira J. 2011. The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro. Antimicrob. Agents Chemother. 55:2696-2703. http://dx.doi.org/10.1128/AAC.01295-10.
42. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods 174:12-21. http://dx.doi.org/10.1016/j.jviromet.2011.03.012.
43. Toth Z, Brulois KF, Wong LY, Lee HR, Chung B, Jung JU. 2012. Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J. Virol. 86:9696-9707. http://dx.doi.org/10.1128/JVI.01012-12.
44. Vieira J, O'Hearn PM. 2004. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325:225-240. http://dx.doi.org/10.1016/j.virol.2004.03.049.
45. Kanda T, Sullivan KF, Wahl GM. 1998. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 8:377-385. http://dx.doi.org/10.1016/S0960-9822(98)70156-3.
46. Lu PJ, Zhou XZ, Liou YC, Noel JP, Lu KP. 2002. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 277:2381-2384. http://dx.doi.org/10 .1074/jbc.C100228200.
47. Ruan L, Torres CM, Qian J, Chen F, Mintz JD, Stepp DW, Fulton D, Venema RC. 2011. Pin1 prolyl isomerase regulates endothelial nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 31:392-398. http://dx.doi .org/10.1161/ATVBAHA.110.213181.
48. Carroll KD, Khadim F, Spadavecchia S, Palmeri D, Lukac DM. 2007. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein Octamer-1 and DNAare critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation. J. Virol. 81:8451-8467. http://dx.doi .org/10.1128/JVI.00265-07.
49. Bu W, Palmeri D, Krishnan R, Marin R, Aris VM, Soteropoulous P, Lukac DM. 2008. Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization. J. Virol. 82:10709-10723. http://dx.doi.org/10.1128/JVI.01012-08.
50. Hennig L, Christner C, Kipping M, Schelbert B, Rucknagel KP, Grabley S, Kullertz G, Fischer G. 1998. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37:5953-5960. http://dx.doi.org/10.1021/bi973162p.
51. Smet-Nocca C, Launay H, Wieruszeski JM, Lippens G, Landrieu I. 2013. Unraveling a phosphorylation event in a folded protein by NMR spectroscopy: phosphorylation of the Pin1 WW domain by PKA. J. Biomol.NMR55:323-337. http://dx.doi.org/10.1007/s10858-013-9716-z.
52. Eckert B, Martin A, Balbach J, Schmid FX. 2005. Prolyl isomerization as a molecular timer in phage infection. Nat. Struct. Mol. Biol. 12:619-623. http://dx.doi.org/10.1038/nsmb946.
53. Cho YS, Park SY, Kim DJ, Lee SH, Woo KM, Lee KA, Lee YJ, Cho YY, Shim JH. 2012. TPA-induced cell transformation provokes a complex formation between Pin1 and 90 kDa ribosomal protein S6 kinase 2. Mol. Cell. Biochem. 367:85-92. http://dx.doi.org/10.1007/s11010-012-1322-y.
54. Khanal P, Choi HK, Namgoong GM, Ahn SG, Yoon JH, Sohn H, Choi HS. 2011. 5=-Nitro-indirubinoxime inhibits epidermal growth factor-and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1. Mol. Carcinog. 50:961-971. http://dx .doi.org/10.1002/mc.20761.
55. Li M, Stukenberg PT, Brautigan DL. 2008. Binding of phosphatase inhibitor-2 to prolyl isomerase Pin1 modifies specificity for mitotic phosphoproteins. Biochemistry 47:292-300. http://dx.doi.org/10.1021/bi701819k.
56. Guito J, Lukac DM. 2012. KSHV Rta promoter specification and viral reactivation. Front. Microbiol. 3:30. http://dx.doi.org/10.3389/fmicb .2012.00030.
57. Lee TH, Tun-Kyi A, Shi R, Lim J, Soohoo C, Finn G, Balastik M, Pastorino L, Wulf G, Zhou XZ, Lu KP. 2009. Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat. Cell Biol. 11:97-105. http://dx.doi.org/10.1038/ncb1818.
58. Liao Y, Wei Y, Zhou X, Yang JY, Dai C, Chen YJ, Agarwal NK, Sarbassov D, Shi D, Yu D, Hung MC. 2009. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation. Oncogene 28:2436-2445. http://dx.doi.org/10 .1038/onc.2009.98.
59. Rustighi A, Tiberi L, Soldano A, Napoli M, Nuciforo P, Rosato A, Kaplan F, Capobianco A, Pece S, Di Fiore PP, Del Sal G. 2009. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol. 11:133-142. http://dx.doi.org/10.1038/ncb1822.
60. Wulf GM, Liou YC, Ryo A, Lee SW, Lu KP. 2002. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277:47976-47979. http://dx.doi.org/10.1074/jbc.C200538200.
61. Le Clorennec C, Ouk TS, Youlyouz-Marfak I, Panteix S, Martin CC, Rastelli J, Adriaenssens E, Zimber-Strobl U, Coll J, Feuillard J, Jayat-Vignoles C. 2008. Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis. J. Virol. 82:6721-6733. http://dx.doi .org/10.1128/JVI.02250-07.
62. Shaw PE. 2007. Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?. EMBO Rep. 8:40-45. http://dx.doi.org/10.1038/sj .embor.7400873.
63. Ryo A, Uemura H, Ishiguro H, Saitoh T, Yamaguchi A, Perrem K, Kubota Y, Lu KP, Aoki I. 2005. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 11: 7523-7531. http://dx.doi.org/10.1158/1078-0432.CCR-05-0457.
64. Rossetto CC, Susilarini NK, Pari GS. 2011. Interaction of Kaposi's sarcoma-associated herpesvirus ORF59 with oriLyt is dependent on binding with K-Rta. J. Virol. 85:3833-3841. http://dx.doi.org/10.1128/JVI.02361-10.
65. Wang Y, Li H, Chan MY, Zhu FX, Lukac DM, Yuan Y. 2004. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cisacting requirements for replication and ori-Lyt-associatedRNAtranscription. J. Virol. 78:8615-8629. http://dx.doi.org/10.1128/JVI.78.16.8615-8629.2004.
66. Wang Y, Li H, Tang Q, Maul GG, Yuan Y. 2008. Kaposi's sarcomaassociated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors. J. Virol. 82:2867-2882. http://dx.doi.org/10.1128/JVI.01319-07.
67. Lim YS, Tran HT, Park SJ, Yim SA, Hwang SB. 2011. Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation. J. Virol. 85:8777-8788. http://dx.doi.org/10.1128/JVI.02533-10.
68. Milbradt J, Webel R, Auerochs S, Sticht H, Marschall M. 2010. Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus. J. Biol. Chem. 285: 13979-13989. http://dx.doi.org/10.1074/jbc.M109.063628.
69. Nicholson LK, Lu KP. 2007. Prolyl cis-trans isomerization as a molecular timer in Crk signaling. Mol. Cell 25:483-485. http://dx.doi.org/10.1016/j .molcel.2007.02.005.